Cocrystal Pharma, Inc. — Director's Dealing 2020

Jun 24, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cocrystal Pharma, Inc. (COCP)
CIK: 0001412486
Period of Report: 2020-06-22

Reporting Person: FROST PHILLIP MD ET AL (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-06-22	Stock Options (Right to Buy)	$1.33	A	50000	Acquired	2030-06-22	Common Stock (50000)	Direct

Footnotes

F1: The stock options vest as follows: 25,000 stock options will vest on the one year anniversary of the grant date and the remaining 25,000 stock options will vest in eight equal quarterly increments with the first such quarterly increment vesting on September 30, 2021.